N-acetyl beta alanine methods of use
AssigneeThermoLife International, LLC
InventorsRonald Kramer, Alexandros Nikolaidis
Life of this patent
Estimating the term…
Abstract
Method for preventing paresthesia in a human is disclosed. The method includes administering to the human an effective amount of N-Acetyl Beta Alanine or an N-Acetyl Beta Alanine composition.
Claims7
A method for reducing muscle fatigue or increasing athletic performance in a human comprising, orally administering to the human 1 g to 10 g of N-Acetyl Beta Alanine as an alternative to beta alanine in order to prevent the onset of paresthesia in the human.
A method for increasing absorption of beta alanine in a human while preventing the onset of paresthesia, the method comprising orally administering to the human 1 g to 10 g of N-Acetyl Beta Alanine.
A method for preventing the onset of paresthesia in a human caused by beta alanine supplementation, the method comprising orally administering to the human 1 g to 10 g of N-Acetyl Beta Alanine as an alternative to beta alanine.
Dependencies are inferred from the claim text.